Gallacher Capital Management’s Gilead Sciences GILD Stock Holding History

Gallacher Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$214K	Buy	+1,696	New	+$223K	0.12%	247
2024 Q1	–	Sell	-5,585	Closed	-$452K	–	285
2023 Q4	$452K	Buy	5,585 +1,237	+28%	+$96.3K	0.25%	85
2023 Q3	$326K	Buy	4,348 +1,406	+48%	+$108K	0.2%	126
2023 Q2	$227K	Buy	+2,942	New	+$235K	0.13%	211

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Gallacher Capital Management's GILD Position: Q2 2026 in Review

Gallacher Capital Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,696 shares worth $214K. The stake represents 0.12% of the portfolio and ranks #247 among its holdings. This is a return to the name: Gallacher Capital Management previously reported a position in GILD as recently as Q4 2023.

Gallacher Capital Management first reported a position in GILD in Q2 2023 and has held it in 4 quarters since. The position peaked at $452K in Q4 2023. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Gallacher Capital Management held 1,696 shares of Gilead Sciences worth $214K as of Q2 2026.
Gilead Sciences was a new Gallacher Capital Management position in Q2 2026.
Gilead Sciences made up 0.12% of Gallacher Capital Management's portfolio in Q2 2026, its #247 holding.
Gallacher Capital Management first reported a position in Gilead Sciences in Q2 2023 and has held it in 4 quarters since.
Gallacher Capital Management's Gilead Sciences position peaked at $452K in Q4 2023.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gallacher Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.